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Mutations of Ca
2+-activated proteases (calpains) cause muscular dystrophies. Nevertheless, the speciﬁc role of calpains in Ca
2+
signalling during the onset of dystrophies remains unclear. We investigated Ca
2+ handling in skeletal cells from calpain 3-deﬁcient
mice. [Ca
2+]i responses to caﬀeine, a ryanodine receptor (RyR) agonist, were decreased in −/− myotubes and absent in −/−
myoblasts. The −/− myotubes displayed smaller amplitudes of the Ca
2+ transients induced by cyclopiazonic acid in comparison
to wild type cells. Inhibition of L-type Ca
2+ channels (LCC) suppressed the caﬀeine-induced [Ca
2+]i responses in −/− myotubes.
Hence, the absence of calpain 3 modiﬁes the sarcoplasmic reticulum (SR) Ca
2+ release, by a decrease of the SR content, an impair-
ment of RyR signalling, and an increase of LCC activity. We propose that calpain 3-dependent proteolysis plays a role in activating
supportproteinsofintracellularCa
2+ signallingatastageofcellulardiﬀerentiationwhichiscrucialforskeletalmuscleregeneration.
Copyright © 2009 Govindan Dayanithi et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Calpains are intracellular nonlysosomal cysteine proteases
whose functions are regulated by Ca2+ (see [1] for review).
These proteins indeed display one Ca2+-binding domain on
each of the large and small subunits [2]. The physiological
roles of the calpains are not yet fully understood but as
proteases, they may regulate important cellular functions.
In particular, ubiquitous calpains have been implicated in
a wide variety of processes including apoptosis, myogenic
diﬀerentiation, cellular division and fusion [1]. Calpains
have been shown to play regulatory roles in other cells,2 International Journal of Cell Biology
in which they can inﬂuence gene expression through
the cleavage of speciﬁc transcription factors, aﬀecting cell
viability by controlling apoptosis, and modulating other
cell processes through the cleavage of speciﬁc kinases and
ion channels (reviewed by Carafoli and Molinari; [3]). It
was demonstrated that the absence of the skeletal muscle
speciﬁc calpain 3 (from the corresponding gene capn3)
causes limb girdle muscular dystrophy type 2A (LGMD2A)
[4], a disease that has been linked to a signiﬁcant level
of apoptotic ﬁbres [5]. To better understand the function
of calpain 3 and the pathophysiological mechanisms of
LGMD2A, an adequate model was generated by gene
targeting [6]. The pathological process due to calpain
3 deﬁciency is associated with alterations in membrane
permeability [6] suggesting the possible existence of a
perturbation in homeostasis, especially in the intracellu-
lar Ca2+ concentration ([Ca2+]i) during muscular dystro-
phy.
The identiﬁcation from skeletal muscle of a 94kDa
protein that possesses thiol-dependent proteolytic activity
speciﬁcally directed against the skeletal muscle ryanodine
receptor (RyR) has several implications for the pathogenesis
of LGMD2A [7]. In particular, it makes it possible that
the dysregulation of skeletal muscle functions is, at least in
part, a consequence of the lack of RyR regulation by calpain
3.
Indeed, RyR, also referred to as Ca2+-release channel,
is the key protein responsible for the extremely rapid
movement of Ca2+ (millions of ions per second) from the
internal stores named the sarcoplasmic reticulum (SR) to
the cytosol during the process of excitation-contraction
coupling. The latter is described by a plasma membrane
depolarisation coming from motor neurones and activating
dihydropyridine receptors or L-type Ca2+ channels (LCCs)
mechanically coupled to the skeletal RyR isoform 1. In
turn, Ca2+ release from RyR causes the contractile ﬁlaments
to slide along one another, thus triggering the twitch of
the muscle cell. Then Ca2+ has to be removed from the
cytosol by extrusion through the Na+/Ca2+ exchanger and
by reuptake into the SR by the sarcoplasmic/endoplasmic
reticulum Ca2+ ATPase (SERCA) pump. Hence Ca2+ cycling
is a ﬁne-tuned process that requires strong control of its
homeostasis.
To test the hypothesis of RyR modulation by calpain
3, we investigated the eﬀect of caﬀeine, a potent activa-
tor of RyR, and cyclopiazonic acid (CPA), an inhibitor
of the SERCA pump, on [Ca2+]i, which controls the
excitation-contraction coupling in muscle. We measured
[Ca2+]i in primary cultures of normal and capn3-deﬁcient
mice skeletal muscle cells by single cell fast ﬂuorescence
microspectroﬂuorometry. In vivo, satellite cells are activated
into myoblasts, proliferate and fuse to form myotubes to
repair damaged muscle ﬁbres. By comparing myoblasts
and myotubes in culture, we aimed to investigate the
diﬀerent steps involved in the process of regeneration.
Our pharmacological approach enabled us to decipher the
mechanisms leading to an impairment of Ca2+ release in
skeletal muscle when calpain 3 is absent, as it might be the
case in LGMD2A patients.
2.MaterialandMethods
2.1. Generation of capn3-Deﬁcient Mice. The production of
capn3 −/− mice was carried out according to the well
established procedure published in 2000 by Richard and
collaborators [6].
2.2. Primary Skeletal Muscle Cell Culture. Muscles were
excised from the upper and lower legs of adult mice, and
proliferating satellite cells were isolated from these muscles
by pronase digestion as previously described [8]. Cells were
seeded in gelatine-coated (0.5%) glass bottom culture dishes
(HBSt or GWSt-3522 series; 22mm diameter, 0.17mm
thickness; WillCo Wells BV- Amsterdam, Netherlands) at
2 × 103 cells per cm2 in Dulbecco’s Modiﬁed Eagle Medium
(DMEM) containing 20% foetal calf serum, and incubated
at 37
◦Ci n7 . 5 %C O 2. Cells were continuously grown in this
medium, which was replaced at day 3 and then every 4 days.
Proliferating satellite cells were kept in culture for up to 11
days.
2.3. Indirect Immunoﬂuorescence. Indirect immunoﬂuores-
cencewasdoneasdescribedbyMartinetal.in1997[9]using
appropriate dilutions of primary and secondary ﬂuorescent
antibodies. The samples were observed with a Leica TCS 4D
confocal microscope.
2.4. Dye Loading and Measurement of [Ca2+]i. Dye loading
and intracellular free calcium measurements ([Ca2+]i)w e r e
performed as described [10–12]. The culture dishes were
rinsed and incubated with 2.5μM fura-2-AM and 0.05%w/v
Pluronic F-127 (Molecular Probes, Inc USA) in Locke
Locke’s buﬀer (in mM): NaCl 140; KCl 5; MgCl2 1.2; CaCl2
2.2; glucose 10; HEPES-Tris 10; pH 7.25) at 34
◦Cf o r4 5
min. Subsequently, loaded cells were rinsed with Locke’s
buﬀer, and ﬂuorescence measurements were carried out in
buﬀers kept at 35–37
◦C throughout the time course of the
experiment.Calcium-freemedium(EGTA-buﬀer)contained
(mM): EGTA, 2; NaCl, 140; KCl, 5; glucose, 10; KCl, 5;
MgCl2, 1; and HEPES 10; pH 7.4. In this EGTA buﬀer,
free Ca2+ was adjusted to 100nM (which corresponds to
the resting [Ca2+]i as determined by preliminary fura-2
measurements). [Ca2+]i levels in single cells were measured
using the FFP photometer system (Zeiss, Oberkochen,
Germany) based on an inverted microscope (Axiovert-100)
equipped with epiﬂuorescence. Band pass ﬁlters (340/10
nm and 380/10nm) were alternately positioned with a
ﬁlter wheel, and the cells were excited through an oil-
immersion objective (Zeiss-plan Neoﬂuar ×100, 1.3n.a).
With ﬂuorescence values corrected for background and dark
current, [Ca2+]i was calculated from the ratio between 340
and 380 nm recordings. For the in vitro calibration of
[Ca2+]i measurements based on the procedure described
by Grynkiewicz et al. [13], we used Ca2+-EGTA buﬀer
containing (mM): NaCl 140; MgCl2 2; glucose 10; HEPES
10 at pH = 7.25 adjusted with Tris-HCl. Various standards
were used for system calibration as described previously
[13].International Journal of Cell Biology 3
2.5. Drugs. Unless otherwise stated, all chemicals were pur-
chased from Sigma-France. Concentrated stock DMSO solu-
tions of cyclopiazonic acid (CPA) and ryanodine (Alomone
Labs, Israel) were stored at −20
◦C. Caﬀeine (Almone Labs,
Isreal) was dissolved directly in the working buﬀer at
appropriate concentrations. Test solutions were prepared
daily using aliquots from frozen stocks to obtain the working
concentrations.
2.6. Drug Application. The control and test solutions were
applied using a multiple capillary perfusion system (200μm
inner diameter capillary tubing, ﬂow rate 500μl/min) placed
close to the cell tested (<0.5mm). Each capillary was fed by a
reservoir 50cm above the bath. Switching the opening from
one capillary to the next made complete solution changes.
After each application, the cells were washed with Locke’s
buﬀer. Preincubation with inhibitory substances was carried
out in a 500μL bath containing the inhibitors diluted in
Locke’s buﬀer.
2.7. Data Analysis and Statistical Methods. The results are
expressed as mean ± S.D or means ± S.E.M.T h en u m b e r
of sample size (n) given is the number of cells tested with
the same protocol (control, test drug, recovery) for each
group. The ﬁgures (traces) show on-line measurements of
the [Ca2+]i levels before and after the application of test
substances, while bar diagrams and numerical data are given
as mean ± S.E.M. and represent the peak amplitude of
the [Ca2+]i increase. Depending on the data, the results
were analysed using ANOVA or Mann-Whitney Rank Sum
test. Unless otherwise stated, diﬀerences were considered
statistically signiﬁcant if P<0.05.
2.8. Western Blot. Muscle samples were homogenized in
200mM sucrose, 0.4mM CaCl2, 20mM HEPES (pH 7.4),
200μM phenylmethylsulfonylﬂuoride (PMSF), 1mM diiso-
propylﬂuorophosphate (DFP). Protein samples were dena-
tured 30 min at room temperature and subjected to SDS-
PAGE on 4%–15% acrylamide gradient gels and electro-
transferred to Immobilon membranes for 3 hours at 0.8A.
Themembranewasblockedwith4%nonfatdrymilkinPBS,
0.1% Tween 20 (PBS-T) for 30 minutes at room temperature
and then incubated overnight at 4◦C with a polyclonal rabbit
antibody against RyR diluted 1/10000 [14]. After washing in
PBS-T, the membrane was incubated for 3 hours at room
temperature with antirabbit secondary antibodies (Jackson
ImmunoResearch Laboratories) coupled to horseradish per-
oxidase. Revelation was carried out with a chemiluminescent
reagent(WesternlightningChemiluminescencereagentplus,
Perkin Elmer). Band intensities were quantiﬁed using ImageJ
software(NationalInstitutesofHealth,Bethesda,MD,USA).
2.9. RT-PCR Analysis. Total RNA was extracted from mus-
cles by the Trizol method (Invitrogen) after pulverization
using a Fast Prep FP120 apparatus (Bio101). Residual DNA
was removed from the samples using the Free DNA kit
(Ambion). One μg of RNA was reverse-transcribed using
random hexamers according to the protocol “Superscript II
ﬁrst strand synthesis system for RT-PCR” (Invitrogen). PCR
was carried out on 1/20 of the reaction with 0.2μMo fe a c h
primer. Three primer pairs were designed for capn3 in order
to cover the regions of alternative splicing [4] as follows:
p94sys3: forward 5 -TTCACCAAATCCAACCAC-
CG-3  and reverse 5 -ACTCCAAGAACCGTTCCA-
CT-3 ;
p94sys5: forward 5 -AGACAAAGATGAGAAGGC-
CC-3  and reverse 5 -GCCGATCCACAGAGATTG-
TA-3 ;
p94sys6: forward 5 -GACAGAGCACACAGCAAC-
AA-3  and reverse 5 -GTTGGCTGTTGAGATGGA-
AG-3 .
PCR products were separated by agarose gel elec-
trophoresis and stained with ethidium bromide. Band
intensities were quantiﬁed using ImageJ software (National
Institutes of Health, Bethesda, MD, USA).
2.10. Caspase 3 Activity. To determine and quantify caspase
3 function, we used the PhiPhiLux-G2D2 substrate kit
(OncoImmunin, Inc., MD, USA). Brieﬂy, the substrate is
coupled to a ﬂuorophore and when cleaved speciﬁcally by
caspase 3, the ﬂuorescence can be detected, measured and
analysed (excitation and emission peaks are 552 and 580nm,
resp.).
3. Results
3.1. Morphological and Molecular Characterisation of Living
Myoblasts and Myotubes. We ﬁrst characterised the diﬀer-
entiated states of the skeletal muscle primary cultures used
in this study by the expression of speciﬁc diﬀerentiation
markers. At day 6 of culture, mononuclear cells from both
wild type (Figure 1(a), left upper panel) and capn3-deﬁcient
(not shown) mice were uniformly positive for myogenin
(Figure 1(a), left medium panel) and negative for MHC
(Figure 1(a), left lower panel) conﬁrming that they were
diﬀerentiated myoblasts. After 11 days in culture, cells
became multinucleated (Figure 1(a), right upper panel), and
the myogenin staining was strongly reduced (Figure 1(a)
right medium panel); in contrast, cells expressed prominent
MHC staining (Figure 1(a) right lower panel). Therefore, at
that time most myoblasts had fused into myotubes, showing
a serum-induced further diﬀerentiation over culturing time,
and thus for both conditions wild type and capn3-deﬁcient
(not shown) mice. As a result, in subsequent single-cell
Ca2+ measurements myoblasts and myotubes were probed
independently as they exhibit diﬀerent diﬀerentiation states.
In a second set of experiments we analysed capn3
expression in myoblasts and myotubes from normal and
capn3-deﬁcient mice. RT-PCR was carried out with RNA
extracted from the myoblast and myotube diﬀerentiation
stages and with speciﬁc primers covering in particular the
regions of capn3 alternative splicing [4]. Only weak expres-
sion was detected on capn3-deﬁcient cells (data not shown;
[6]) whereas it was present in normal cells at both stages.
In addition, the diﬀerentiation process in this cell culture4 International Journal of Cell Biology
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Figure 1: Morphological and molecular features of skeletal muscle cells used throughout this study. (a) Phase contrast and ﬂuorescence
micrographs of murine skeletal muscle cells in primary culture. Typical morphology of the living cells (left upper panel: myoblasts;
right upper panel: myotubes) used for calcium measurements observed by phase contrast microscopy. Circles indicate the region of drug
application and monitoring of [Ca2+]i. Immunological staining of myogenin on myoblasts (left middle panel) and myotubes (right middle
panel) was visualized by confocal microscopy using a FITC-labelled secondary antibody (green ﬂuorescence). Myosine Heavy Chain (MHC)
was similarly observed in myoblasts (left lower panel) and myotubes (right lower panel) using a TRITC-labelled secondary antibody (red
ﬂuorescence). Myoblasts and myotubes were obtained after 6 or 11 days in culture, respectively. (b) Detection of calpain 3-mRNA in wild
type (+/+) myoblasts and myotubes by RT-PCR. Gel electrophoresis of the RT-PCR reactions obtained using the primer pairs p94sys3,
p94sys5 and p94sys6 (see Section 2) on murine myoblast (MB) or myotube (MT) mRNA. (c) Detection of the ryanodine receptor in skeletal
muscle from normal and capn3-deﬁcient mice. Muscle from normal (Lane 3) and capn3-deﬁcient mice (Lane 2) were extracted and left 30
min at room temperature to allow the cleavage of RyR and were then subjected to SDS-PAGE. Human muscle was used as control (Lane1).
No diﬀerence in the cleavage pattern was observed, indicating that the partial cleavage of RyR also occurs in the absence of calpain 3 in
this biochemical assay. (d) Measurement of caspase 3 activity in wild type and capn3-deﬁcient myoblasts. The graph displays the levels of
substrate cleavage expressed as means ± S.D. in arbitrary units. The results are based on 4 diﬀerent experiments. The diﬀerences in the
median values among the two groups are greater than would be expected by chance; there is a statistically signiﬁcant diﬀerence (P = 0.029),
as indicated by a Mann-Whitney Rank Sum test.
system was accompanied by a change in the expression
pattern of calpain 3 RNA isoforms with alternative splicing
forms mostly expressed in immature cells (see MB lanes in
Figure 1(b) and Table 1 for semiquantiﬁcation).
During the excitation-contraction coupling phenome-
non, RyR releases Ca2+ in response to depolarization of
the plasma membrane. Previous publications reported the
cleavageofRyRbya94kDathiolproteaseintotwofragments
(375 kDa and 150 kDa fragments) [7, 15]. This cleavage
results in an enhancement of Ca2+ eﬄux from SR vesicles.
We examined this protein by western blot in normal and
capn3-deﬁcient whole skeletal muscle samples (Figure 1(c)International Journal of Cell Biology 5
Table 1: Quantiﬁcation of the expression of calpain 3 transcripts
in wild type myoblasts and myotubes. These data were obtained
from the gel electrophoresis of the RT-PCR reactions using the
primer pairs p94sys3, p94sys5 and p94sys6 on murine myoblast
(MB) or myotube (MT) mRNA (see Figure 1(b)). The gel and
the corresponding quantiﬁcation are representative of 3 diﬀerent
experiments where similar results were observed. These results have
to be taken qualitatively since the experiments were performed by
classical RT-PCR and not by quantitative RT-PCR. Numbers are
given in arbitrary units.
Primer p94sys3 p94sys5 p94sys6
Cell type MB MT MB MT MB MT
Band 1 43596 165378 155681 205283 66937 46845
Band 2 207433 89706 73219 69370 45719
Band 3 43022
Total 251029 255084 228900 274653 155678 46845
and Table 2 for semiquantiﬁcation). The cleaved fragments
were obtained in both samples indicating that calpain 3 is
not necessary for cleavage in whole muscle and that it most
likely cannot be involved in the results dealing with the Ca2+
release from RyR in cultivated proliferating satellite cells.
Deﬁciency in calpain 3 is known to be associated with
apoptosis [5] as indicated by increases of caspase 3 activity
[16]. Analysis of the cleavage of a ﬂuorescent substrate
speciﬁcally by caspase 3 was performed in cells at the
myoblast stage. Figure 1(d) highlights the signiﬁcant raise of
caspase3activityincalpain3-deﬁcientcellsincomparisonto
wild type cells. Caspase 3 being a marker for apoptosis, this
result therefore suggests a probable increase of the apoptotic
rate when calpain 3 is lacking in mouse myoblasts.
3.2. Caﬀeine-Induced [Ca2+]i Increase in Isolated Myoblasts
and Myotubes. Caﬀeine, the best known agonist of ryan-
odine receptors [17], was used at 20mM throughout the
study to ensure the complete activation of the RyRs of the
sarcoplasmic reticulum (SR) [18, 19]. [Ca2+]i release by
caﬀeinewastestedonm yoblastsandm yotubesculturedfrom
wild type (+/+) and capn3-deﬁcient (−/−)m i c e( Figure 2).
Resting [Ca2+]i levels in cell types of both +/+ and −/− mice
did not change signiﬁcantly (103 ± 4nM; n = 187). After
local caﬀeine application, +/+ myoblasts showed a single
and slow increase in [Ca2+]i, that peaked after 3 minutes of
caﬀeine application and decayed slowly, even before the caf-
feine was washed out (Figure 2(a)) presumably conﬁrming
the presence at this stage of the Na+/Ca2+ exchanger at the
plasmamembranelevel[20].Thenumberofcellsresponding
to caﬀeine in these cell types is summarised in Figure 3(a).
Thirty-two out of 36 +/+ myoblasts showed an increase in
[Ca2+]i after the application of caﬀeine. No [Ca2+]i response
to caﬀeine was observed for repeated applications (data not
shown) even when the caﬀeine was quickly taken oﬀ.B y
contrast, +/+ myotubes exhibited a constant, repeated and
reproducibleincreasein[Ca2+]i afterbrief(30s)andrepeated
applications of caﬀeine (Figure 2(b)). The mean peak ampli-
Table 2: Western blot quantiﬁcation: cleavage of the ryanodine
receptor in wild type and calpain 3-deﬁcient skeletal muscles.
The gel presented in Figure 1(c) was analysed in terms of band
intensities (numbers are given in arbitrary units). The lower band is
58% of the higher band (ﬁxed to 100%) in lane 2, and 51% in lane
3. The amount of the second band is related to small degradation
condition (time and temperature), but is always identical in the two
situations wild type and calpain 3-deﬁcient skeletal muscles. The
blot and the corresponding quantiﬁcation are representative of at
least 3 independent experiments showing no diﬀerence between the
two types of mice.
Sample 1 = human
skeletal muscle
2 = capn3 −/−
mouse skeletal
muscle
3 = wild type
mouse skeletal
muscle
Band 1 90982 69472 52878
Band 2 92773 32041 38331
Band 3 49076
Total 232831 101513 91209
tude of the [Ca2+]i response is plotted in Figure 3(b).I n
contrast, −/−myoblastsfailedtoexhibitthe[Ca2+]i-induced
response to caﬀeine in a huge majority of cells (Figure 2(c)
and Figure 3(a); 66 cells out of 71). A very small response
was observed in only 5 out of 71 cells (Figure 3(a)). In
contrast to +/+ myotubes, a progressive desensitization of
the [Ca2+]i response to repeated caﬀeine applications (3
min each) was observed in −/− myotubes (Figure 2(d)).
In addition, the peak amplitude of the responses induced
by 3 successive shots of 20 mM caﬀeine observed in −/−
myotubes was signiﬁcantly lower than in wild-type: a 60%,
75% and 90% decrease, respectively (n = 12; Figure 3(c)
versus Figure 3(b)).
3.3.EﬀectofCaﬀeineandCPAon[Ca2+]i inIsolatedMyoblasts
and Myotubes from Wild Type (+/+) and capn3-Deﬁcient
(−/−)M i c e .We then compared the eﬀects of CPA to
those obtained with caﬀeine. CPA is a potent inhibitor
of the sarcoplasmic reticulum (SR) Ca2+-ATPase [21, 22]
and induces Ca2+ mobilization from internal Ca2+ stores,
preferentially depleting InsP3-sensitive stores [23]. In +/+
myoblasts CPA (10μM) induced an increase of [Ca2+]i of
much lower amplitude (Figure 4(a), right peak) than when
induced by a prior exposure to caﬀeine (Figure 4(a);l e f t
peak). Tested on +/+ myotubes, both caﬀeine and CPA
induced a similar [Ca2+]i increase, with a peak amplitude
signiﬁcantly higher (Figure 4(b)) than the one observed
in myoblasts for both drugs (Figure 4(a)). The diﬀerences
found between the responses to caﬀeine and CPA in +/+
myoblasts and +/+ myotubes was found to be signiﬁcant
(P<0.05; Figures 5(a) and 5(b).
Interestingly, in capn3-deﬁcient cells (−/−), the [Ca2+]i
responses to caﬀeine and CPA were quite diﬀerent (Figures
4(c) and 4(d) for the parameters tested. First of all, as already
illustrated in Figure 2(c), the Ca2+ response to caﬀeine in
−/− myoblasts was totally absent (Figure 4(c) left trace),
and of small amplitude in −/− myotubes (Figure 4(d) right
trace). By comparison CPA induced a signiﬁcant [Ca2+]i6 International Journal of Cell Biology
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Figure 2: Eﬀectofcaﬀeine on [Ca2+]i in isolated myoblasts and myotubes. Representative traces show the typical time courseof the response
to 20mM caﬀeine observed in (a) wild type (+/+) myoblast; (b) wild type (+/+) myotube; (c) capn3-deﬁcient (−/−)m y o b l a s t ;( d )capn3-
deﬁcient (−/−) myotube. The duration of drug exposure is represented (open bars).
rise in −/− myoblasts (Figure 4(c) r i g h tp e a k ) ,b u tam u c h
smaller increase in −/− myotubes, even when CPA was
applied before caﬀeine (Figure 4(d) left peak). The peak
amplitude of the various [Ca2+]i responses was quantiﬁed
a n da r es u m m a r i s e di nFigure 5.
3.4. Inﬂuence of the External Ca2+ Concentration and of
Ca2+ Channels at the Plasma Membrane on SR Ca2+ Release.
The [Ca2+]i responses induced by caﬀeine were also tested
in low Ca2+ EGTA-buﬀer to investigate the dependence
upon external Ca2+ in myotubes obtained from wild type
and capn3-deﬁcient (−/−) mice. Indeed, the removal of
extracellular Ca2+ did not signiﬁcantly aﬀect the [Ca2+]i
responses induced by 20mM caﬀeine on +/+ myotubes
(results not shown). However, a major reduction in the
[Ca2+]i response to caﬀeine was observed in −/− myotubes,
in the absence of extracellular Ca2+ (results not shown).
The next experimental design aimed to dissect the
functional interaction between RyR and Ca2+ channels of
the plasma membrane in myoblasts and myotubes of wild
type and capn3-deﬁcient (−/−) mice. In this respect, we
focused our study on myotubes, because −/− myoblasts
appeared insensitive to caﬀeine. We subjected myotubes to
successiveexposurestocaﬀeine,intheabsenceorpresenceof
nonspeciﬁc Ca2+ channel blockers (i.e., a mixture of 100μMInternational Journal of Cell Biology 7
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Figure 3: Peak amplitude of [Ca2+]i response of myoblasts and myotubes to caﬀeine. Bar diagrams summarize the response of the cell types
showninFigure 2.(a)myoblasts(+/+and −/−):singleapplication of20mMcaﬀeine;(b)myotubes(+/+);(c)myotubes (−/−): 3 successive
applications of 20mM caﬀeine. The number of cells pooled in a category and the total number of cells tested are given in brackets.
Cd2+ and 50μMN i C l 2). None of the Ca2+ channel blockers
aﬀected the [Ca2+]i response induced by caﬀeine in +/+
myotubes (Figures 6(a) and 6(b)). In sharp contrast, Ca2+
channel blockers signiﬁcantly reduced the [Ca2+]i response
induced by caﬀeine in −/− myotubes (Figures 6(c) and
6(d)). It is noteworthy that, at the end of the inhibition of
Ca2+ entry (Figures 6(a) and 6(c)), the baseline increased
further suggesting that there was a Ca2+ re-entry in both
types of cells. However, the relative amplitudes of the 4th
and 5th caﬀeine applications were still diﬀerent between +/+
and −/− myotubes. Moreover, after starting the inhibition
of Ca2+ entry (Figure 6(c)), the baseline decreased further
suggesting that there was constitutive Ca2+ entry in −/−
myotubes.Inaddition,inothersetofexperiments,theeﬀects
of various more speciﬁc blockers were examined, among
them the most important Ca2+ channel sub-type blockers,
such as nicardipine (L-type blocker), omega GVIA-N-type,
omega MVIIC/MVIIA-a P/Q type, omega-Aga-IVA (a P/Q-
typeblocker),andSNX-482(aR-typeblocker).Interestingly,
only nicardipine at 800nM signiﬁcantly blocked the Ca2+
response induced by caﬀeine in −/− myotubes (control:
568 ± 32nM; nicardipine: 102 ± 25nM; n = 4; P<0.05)
suggesting that the response could not be directly mediated
by caﬀeine-sensitive channels.
4. Discussion
Calpains are a family of Ca2+-dependent cysteine proteases
(for review articles, see [1–3]), the members of which are
expressed ubiquitously (calpains 1 and 2) or in a tissue-
speciﬁc way (calpain 3 is skeletal muscle speciﬁc and an
isoform of calpain 3 was found in the lens). In addition
to Ca2+ ions, the activation of ubiquitous calpains can
be modulated by association with a 30kD small sub-unit,
or with membranes, by the autolysis of the N-terminus,
or by calpastatin, a speciﬁc inhibitor. Their function in
muscle has received increasing interest because of the ﬁnding
that the activation and concentration of the ubiquitous
calpains were found to be increased in the mouse model
of Duchenne muscular dystrophy (mdx mice). Moreover,
protein degradation was enhanced in mdx muscle [24], and
it was argued that increased degradation resulted from the8 International Journal of Cell Biology
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Figure 4: Eﬀectofcaﬀeine and CPA on [Ca2+]i in isolated myoblasts and myotubes. Representative traces show the typical time course ofthe
response to 20 mM caﬀeine and 10μM CPA observed in (a) wild type (+/+) myoblast; (b) wild type (+/+) myotube; (c) calpain 3-deﬁcient
(−/−) myoblast; (d) calpain 3-deﬁcient (−/−) myotube. The duration of exposure to caﬀeine (open bars) and CPA (gray-dashed bars) is
represented.
elevated Ca2+ levels existing within the dystrophic muscle.
Possible substrates of calpains are the membrane-associated
cytoskeletal proteins, the plasma membrane Ca2+-ATPase,
and the ion channel proteins. Interestingly, the Ca2+ pump
located in the plasma membrane is a preferred substrate
of calpain in erythrocytes [25]. If impaired in dystrophin-
deﬁcient muscle, this calpain action would, in addition to
provoking an excess of Ca2+ inﬂux, disturb an important
extrusion pathway. Calpains in normal tissue supposedly
exert regulatory roles. It is therefore assumed that in the
dystrophic process, a deﬁciency in one of the calpains would
result in aﬀecting a metabolic pathway rather than muscle
proteolysis. Calpains cleave substrates at restricted locations
[3] and are unlikely to be involved in mediating major
house-keepingdegradativefunctions.Thus,currentevidence
supports a role for pathologically-high calpain activity
in muscular dystrophy through the disruption of speciﬁc
regulatory mechanisms in muscle, rather than through an
increase in nonspeciﬁc proteolysis.
In this study we have used mouse primary cultures of
skeletal muscle from normal and capn3 −/− mice recently
generated at Genethon by I. Richard’s laboratory. Capn3-
deﬁcient mice are fully fertile and viable and show a mild
muscular dystrophy that aﬀects a speciﬁc group of muscles.
Interestingly, aﬀected muscles manifest a similar apoptosis-
associated perturbation of the IkappaBalpha/NF-kappaB
pathwayasseeninLGMD2Apatients[5]andcapn3-deﬁcient
mice [6].
The availability of primary cultures of skeletal mus-
cle cells from normal and capn3 −/− mice provides anInternational Journal of Cell Biology 9
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Figure 5: Peak amplitude of [Ca2+]i response of myoblasts and myotubes to caﬀeine and CPA. Bar diagrams summarize the response of
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opportunity to tackle in the near future the upstream and
downstream events occurring during a pharmacologically-
induced[Ca2+]i riseinmyoblastsandmyotubesfromnormal
andcapn3 −/−mice.Notably,itispossiblethatcalpain3acts
as a feedback regulator for calcium homeostasis in skeletal
muscle cells by exerting an action on RyR. The latter, also
known as the Ca2+ release channel of the SR, is a key protein
involved in excitation-contraction coupling. Its activity is
regulated by a 94 kDa thiol-protease of the junctional SR
membranes which speciﬁcally cleaves one site on RyR. This
cleavage results in enhanced Ca2+ eﬄux from SR vesicles
[7, 15].
Importantly, in our hands calpain 3 seemed not to
be necessary for cleavage in skeletal muscles in vitro. The
cleavage of RyR in the absence of calpain 3 (muscle-
speciﬁc) could be due to calpain 1 and/or 2, which are
widely expressed in all cell types. The activity of these
calpains could indeed be redundant in that case. To assess
the activity of ryanodine-sensitive internal Ca2+ stores, we
applied caﬀeine stimulations, caﬀeine being a well-known
potent RyR activator [17].
The eﬀectiveness of caﬀeine in normal myotubes in
comparison to myoblasts indicates a maturation of proper
RyR signalling in culture during the fusion process. Impor-
tantly, both myoblasts and myotubes from capn3 −/− mice
displayed weaker amplitudes of the caﬀeine-induced [Ca2+]i
transients than in normal cells, which could indicate a
lower SR Ca2+ loading state in the KO skeletal cells, a
decreased number of RyR at the SR membrane surface, or
a decreased sensitivity of these receptors but independently
of any cleavage by calpain 3.
While CPA, a compound that depletes internal Ca2+
stores [26], evoked increases of [Ca2+]i under all conditions
tested, it appeared that those responses were weaker in
capn3 −/− myotubes in comparison to wild-type myotubes,
reinforcing the hypothesis that SR Ca2+ loading decreased
in capn3 −/− myotubes or indicating that SR Ca2+-ATPases
were less expressed or less sensitive to the blocker in KO
myotubes. The diﬀerence in CPA responses between wild-
type myoblasts and myotubes is most likely due to a change
in the size of the SR that correlates with a change in the size
ofthecellsduringfusioninculture,myotubeshavingalarger
area.
Caﬀeine is thought to directly activate RyR at the SR
membrane, leading to the opening of this channel and the
release of Ca2+ from the SR into the cytosol, independently
of any Ca2+ inﬂux through the plasma membrane. The fact
that low extracellular Ca2+ and blockers of LCCs abolished10 International Journal of Cell Biology
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caﬀeine-induced [Ca2+]i increases in −/− myotubes suggests
that RyR opening and SR Ca2+ release lead to a Ca2+
inﬂux through LCCs solely in the KO myotubes. Since
cytosolic Ca2+ is known to negatively regulate these channels
(inactivation) and that the release from the SR is not
suﬃcient to evoke a depolarization enabling the opening of
LCCs [27], it is most likely that an additional channel at the
plasma membrane induces a depolarization in response to
the caﬀeine-evoked [Ca2+]i increases in −/− myotubes.
Finally, another possibility would be that the lack of
calpain 3 leads to a decrease of RyR sensitivity to caﬀeine,
probably involving a regulation of the post-translational
maturation of the receptor, and thus independently of
any functional cleavage of RyR. It is noteworthy that RyR
contains many endogenous cysteines in the cytoplasmic
domain of the protein. Hence the binding of caﬀeine to its
site on the cytosolic face of RyR would require an activation
of RyR by extracellular Ca2+ entry in order to induce the
proper opening of the receptor.
Taken together, the results obtained in −/− myotubes
indicate: (i) a decrease of the SR load, (ii) an alteration
of RyR signalling, (iii) an increase of LCC activity (i.e.,
constitutive Ca2+ entry), but (iv) no increase of the basal
intracellularCa2+ concentration.AsthemajorsystemofCa2+
extrusion from the cytosol is the Na+/Ca2+ exchanger, it is
very tempting to speculate that the activity of the exchangers
could be increased (higher protein expression and/or higher
rate of ion ﬂow) in KO myocytes to maintain the level of
Ca2+ in the cells.However, this willbe thesubjectforanother
speciﬁc investigation.
In conclusion, by using a knockout strategy, we could
induceaskeletalmuscledystrophyinmiceduetotheabsenceInternational Journal of Cell Biology 11
of calpain 3 and thus draw a general picture of the cellular
pathways involved in this disease. The LGMD2A dystrophy
is characterised by (i) an increase of caspase 3 activity,
(ii) a deregulation of the I{kappa}B{alpha}/NF-{kappa}B
pathway leading to apoptosis [5, 16], (iii) an increase of
membrane permeability, (iv) a decrease in the size of the
SR and v) a dysfunction of RyR signalling. Indeed, our
pharmacological study sheds more light on the mechanism
of Ca2+ remodelling in the failing skeletal muscle, and we
propose a major regulatory role for capn3 on SR Ca2+
release, probably mediated by an increased participation
of LCC in Ca2+ entry to compensate for the alteration of
SR functionality. Moreover, calpain-dependent proteolysis
might be involved not only in the regulation of RyR channels
themselves, but also in the activation by splitting of RyR
auxiliary proteins forming the RyR1 multi-protein complex.
Of interest, recent work from our group showed that not
calpain 3, but μ-calpain is important for the phenomenon
ofexcitation-contraction(Ca2+-induced)uncouplinginnor-
mal and capn3 −/− skeletal muscle ﬁbres [28], suggesting
that the pattern of activities and functions of the diﬀerent
calpains is quite complex and that each calpain seems to play
av e r ys p e c i ﬁ ca n dd e ﬁ n e dr o l ei nt h er e g u l a t i o no fC a 2+
signalling.
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